Clinical Trial Update: Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of an oral killed Enterotoxigenic Escherichia coli vaccine to prevent diarrhea in Egyptian infants and young children has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• Oral killed Enterotoxigenic Escherichia coli vaccine (Enterotoxigenic Escherichia coli vaccine (oral, killed))

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Diarrhea | Phase 3 | Status: COMPLETED